JPRN-UMIN000013324已完成2 期
A phase II study of resection followed capecitabine + oxaliplatin for liver metastasis of colorectal cancer. [REX study] - A phase II study of resection followed capecitabine + oxaliplatin for liver metastasis of colorectal cancer. [REX study]
Hyogo College of Medicine, Department of Surgery0 个研究点目标入组 25 人开始时间: 2014年3月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Synchronous multiple malignancy (2)Previously treated L-OHP. (3) More than 180days after the last chemotherapy. (4)Pregnant or nursing. (5) Severe peripheral neuropathy. (6) History of severe anaphylaxis or allergia (7)Active infection (8)Severe mental disorder. (9) Severe comorbidity. (10)Systemic steroid user. (11)Patients under treatment with flucytosine,phenytoin,warfarin potassium. (12)Hepatitis B virus infection. (13)Watery diarrhea. (14)Consider not appropriate for the study.
研究者
相似试验
进行中（未招募）
2 期
OGSG 1701advanced gastric cancer with lymph node metastases cannot be resected curatively, or poor prognosis.JPRN-jRCTs051180186SUGIMOTO Naotoshi30
已完成
2 期
A phase II study of perioperative capecitabine plus Oxaliplatin(CapeOx) therapy for advanced gastric cancer with multiple lymph node metastases (OGSG 1701)Gastric CancerJPRN-UMIN000028749Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)30
进行中（未招募）
1 期
Phase II neoadjuvant study evaluating capivasertib plus fulvestrant vs fulvestrant in patients with primary high-risk lobular breast cancer- LOBSTERCTIS2023-509292-17-00GBG Forschungs GmbH120
已完成
不适用
Phase II study of surgical resection following neoadjuvant chemoradiation using Gemcitibine and TS-1 in patients with potentially and borderline resectable pancreatic cancerpotentially and borderline resectable pancreatic cancerJPRN-UMIN000003629Kansai Medical University Hospital30
进行中（未招募）
不适用
Phase I/II Studie zum Einsatz von Capecitabin und Oxaliplatin (XELOX) in Kombination mit Bevacizumab und Imatinib in der Erstlinientherapie von Patienten mit fortgeschrittenem kolorektalem Karzinomfortgeschrittenes kolorektalen Karzinom mit inoperablen MetastasenMedDRA version: 9.1Level: LLTClassification code 10010035Term: Colorectal cancer stage IVEUCTR2007-000233-18-DEniversität zu Köln